"Key Considerations for Seniors Exploring Ozempic and Other Weight-Loss Medications"

Weight-loss drugs, such as Ozempic and Mounjaro, are showing promise in helping older adults lose weight, but there are concerns about their long-term effects and the high cost of these medications. Clinical trials have not included significant numbers of people aged 65 and older, leaving gaps in the available data. Medicare does not currently cover weight-loss medications, making it difficult for seniors to access these drugs. A bipartisan group of lawmakers has introduced the Treat and Reduce Obesity Act to require Medicare coverage for weight-loss drugs, but concerns over the potential costs have stalled the proposal. Experts recommend these medications for older adults with a body mass index (BMI) over 30 or a BMI of 27 or above with obesity-related conditions. However, BMI may not accurately estimate body fat in older adults, so other factors like waist circumference should also be considered. Weight loss in older adults should be accompanied by physical activity and a balanced diet to preserve muscle mass and overall health.